oncology research

August 19, 2025

Sara Project at the IIS Aragón: the challenge of developing more potent and less harmful cancer drugs

Developed by the Molecular Oncology Group at the IIS Aragón, led by Alberto J. Schuhmacher, it is based on an innovative technology that uses nanobodies derived from dromedaries.